Identification of Genes Activated By Bile Acids
胆汁酸激活基因的鉴定
基本信息
- 批准号:7460555
- 负责人:
- 金额:$ 36.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetaminophenAcuteAdenovirusesAdrenal CortexAdrenal Gland CarcinomaAdrenal GlandsAffectAmino Acid MotifsBacteriaBacterial InfectionsBile AcidsBindingCellsComplementDNA Binding DomainDataDisruptionEndotoxinsGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionGlucoseGoalsGram-Positive BacteriaGrantHepaticHepatotoxicityHomeostasisHumanHypoglycemiaImmune responseIndividualInfectious AgentInjuryIntestinesLigandsLipidsLipopolysaccharidesLiverLiver FailureMetabolic PathwayModelingMusNumbersPathway interactionsPhosphorylationPlasmaPost-Translational Modification SiteProcessProtein IsoformsProteinsReceptor ActivationRegulationRelative (related person)ResearchResistanceResponse ElementsRoleSeptic ShockShockSteroidsTestingThinkingToxic effectTransactivationTranscriptTranscriptional ActivationTransgenic OrganismsXenobioticsbaseblood glucose regulationchromatin immunoprecipitationdrug metabolismfarnesoid X-activated receptorglucose metabolismhypolipidemiain vivonoveloxidationprotective effectreceptorresearch studytranscription factor
项目摘要
DESCRIPTION (provided by applicant): The major goals of our research have been to identify the mechanisms of activation of the farnesoid X receptor (FXR) and to define its role in regulating metabolic pathways. To this end, we have identified four human and murine FXR transcripts derived from a single gene that encode four different protein isoforms. Our identification of a four amino acid motif (MYTG), located immediately adjacent to the DNA binding domain of two of the four isoforms, dramatically altered our thinking about this transcription factor; new and exciting data suggest that the presence of this motif affects transactivation of certain hepatic and adrenal genes. We have recently discovered that activated FXR has a pronounced effect on glucose metabolism in mice and is highly protective against the acute hepatoxicity produced by toxic xenobiotics and from the toxic effects of IPS (lipopolysaccharide). We have also recently obtained evidence that FXR regulates a number of steroidogenic genes, suggesting a functional role for FXR in the adrenal cortex. Based on these data, generated during the current grant period, we propose to conduct mechanistic studies to elucidate the roles of FXR in i) the control of plasma glucose levels and hepatic glucose metabolism, ii) the control of plasma and hepatic lipid levels, iii) protection of the liver from damage induced by xenobiotics such as acetaminophen, iv) protecting mice from endotoxin shock and bacterial infection and v) the regulation of target genes in adrenal steroidogenic cells. These studies will be aided by the availability of FXR transgenic and FXR-/- mice, and mice lacking FXR in the liver or intestine, and adenovirus expressing individual FXR isoforms. To complement these approaches, mechanistic studies will be conducted to elucidate the function of the MYTG motif present in two of the four FXR isoforms. Taken together, these studies will identify novel regulatory mechanisms by which FXR isoforms activate transcription. In addition, these studies will elucidate the role of FXR in glucose, steroid and drug metabolism and in resistance to endotoxin.
描述(由申请人提供):我们研究的主要目标是确定法内甾体X受体(FXR)的激活机制,并确定其在调节代谢途径中的作用。为此,我们鉴定了四种人类和小鼠FXR转录本,这些转录本来自一个编码四种不同蛋白质亚型的基因。我们发现了一个四氨基酸基序(MYTG),它位于四个亚型中的两个的DNA结合域附近,极大地改变了我们对这个转录因子的看法;新的和令人兴奋的数据表明,该基序的存在影响某些肝脏和肾上腺基因的转激活。我们最近发现,激活的FXR对小鼠的葡萄糖代谢有显著的影响,并对有毒外源性药物和IPS(脂多糖)的毒性作用产生的急性肝毒性具有高度的保护作用。我们最近也获得了FXR调节许多类固醇基因的证据,这表明FXR在肾上腺皮质中具有功能作用。基于这些数据,我们计划开展机制研究,以阐明FXR在以下方面的作用:1)控制血糖水平和肝脏糖代谢,2)控制血浆和肝脏脂质水平,3)保护肝脏免受对乙酰氨基酚等外源性药物的损伤,4)保护小鼠免受内毒素休克和细菌感染,5)调节肾上腺甾体源性细胞中的靶基因。这些研究将得到FXR转基因和FXR-/-小鼠,肝脏或肠道缺乏FXR的小鼠,以及表达单个FXR亚型的腺病毒的帮助。为了补充这些方法,将进行机制研究来阐明MYTG基序在四个FXR亚型中的两个中的功能。综上所述,这些研究将确定FXR异构体激活转录的新调控机制。此外,这些研究将阐明FXR在葡萄糖、类固醇和药物代谢以及对内毒素的抗性中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter A Edwards其他文献
Focal middle cerebral artery ischemia in rats via a transfemoral approach using a custom designed microwire
使用定制设计的微丝通过股动脉途径实现大鼠局灶性大脑中动脉缺血
- DOI:
10.1136/neurintsurg-2014-011607 - 发表时间:
2015 - 期刊:
- 影响因子:4.8
- 作者:
A. Divani;Ricky Chow;H. Sadeghi;Amanda J Murphy;J. Nordberg;Julian V. Tokarev;M. Hevesi;Xiao Wang;Xiao;Tommy Acompanado;Peter A Edwards;Yi Zhang;Wei Chen - 通讯作者:
Wei Chen
Peter A Edwards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter A Edwards', 18)}}的其他基金
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
肝脏代谢调节中 FXR 依赖性新分子机制
- 批准号:
9889118 - 财政年份:2019
- 资助金额:
$ 36.62万 - 项目类别:
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
肝脏代谢调节中 FXR 依赖性新分子机制
- 批准号:
10320000 - 财政年份:2019
- 资助金额:
$ 36.62万 - 项目类别:
Novel transcriptional regulators of bile acid metabolism and hepatotoxicity
胆汁酸代谢和肝毒性的新型转录调节因子
- 批准号:
8670488 - 财政年份:2014
- 资助金额:
$ 36.62万 - 项目类别:
Novel transcriptional regulators of bile acid metabolism and hepatotoxicity
胆汁酸代谢和肝毒性的新型转录调节因子
- 批准号:
8811942 - 财政年份:2014
- 资助金额:
$ 36.62万 - 项目类别:
ABC Transporters in Inflammation and Lipid Homeostasis
炎症和脂质稳态中的 ABC 转运蛋白
- 批准号:
7647664 - 财政年份:2009
- 资助金额:
$ 36.62万 - 项目类别:
REGULATION OF MEVALONIC ACID AND CHOLESTEROL METABOLISM
甲羟戊酸和胆固醇代谢的调节
- 批准号:
6644320 - 财政年份:2002
- 资助金额:
$ 36.62万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Operating Grants














{{item.name}}会员




